Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
| 1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
| a) | Name |
Timothy McCutcheon | ||||
|
| ||||||
| 2 | Reason for the notification
| |||||
| a) | Position/status |
Non-Executive Director, PDMR
| ||||
| b) | Initial Notification Amendment |
Initial Notification
| ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ovoca Bio plc
| ||||
| b) | LEI | 213800ST2AK5XQ1O5207
| ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
| b) | Nature of the transaction |
Purchase of Ordinary Shares
| ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
| e) | Date of the transaction |
12 July 2024
| ||||
| f) | Place of the transaction |
Outside of a trading venue
| ||||
| g) | Additional Information |
Following this transaction, Mr McCutcheon has an interest in 19,506,203 Ordinary Shares in Ovoca Bio plc, or 23.92% of the Issued Share Capital of the Company (excl. Treasury Shares) | ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
| 1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
| a) | Name |
Kirill Golovanov | ||||
|
| ||||||
| 2 | Reason for the notification
| |||||
| a) | Position/status |
Chief Executive Officer, PDMR
| ||||
| b) | Initial Notification Amendment |
Initial Notification
| ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ovoca Bio plc
| ||||
| b) | LEI | 213800ST2AK5XQ1O5207
| ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
| b) | Nature of the transaction |
Disposal of Ordinary Shares
| ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
| e) | Date of the transaction |
12 July 2024
| ||||
| f) | Place of the transaction |
Outside of a trading venue
| ||||
| g) | Additional Information |
Following this transaction, Mr. Golovanov no longer holds any Ordinary Shares in Ovoca Bio plc
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.